Evidence map›Paper›PMID 39857951›Full record

ArticleCancers2025

Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer.

Jonathan Ejie, Amir Ashraf Ganjouei, Sophia Hernandez, Jaeyun Jane Wang, Fernanda Romero-Hernandez, Laleh Foroutani, Kenzo Hirose, Eric Nakakura, Carlos Uriel Corvera, Adnan Alseidi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan EjieDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0009-0002-7912-5211
Amir Ashraf GanjoueiDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Sophia HernandezDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Jaeyun Jane WangDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-3705-3993
Fernanda Romero-HernandezDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Laleh ForoutaniDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Kenzo HiroseDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Eric NakakuraDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Carlos Uriel CorveraDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Adnan AlseidiDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Mohamed Abdelgadir AdamDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Comprehensive evaluation of guideline-concordant care (GCC) across all PDAC stages has yet to be thoroughly conducted. This study aimed to characterize treatment patterns and assess factors associated with receiving GCC among patients with pancreatic ductal adenocarcinoma (PDAC) in California. (2) Methods: Data on adult patients with PDAC were extracted from the California Cancer Registry (2004-2020). GCC is defined according to the recommendations provided by the National Comprehensive Cancer Network. We used multivariable logistic regression to identify factors associated with receiving GCC. A Cox model was used to examine the association of GCC with overall survival. (3) Results: A total of 50,346 PDAC patients were included (stage 1: 10%; stage 2: 25%; stage 3: 11%; stage 4: 54%). Only 46.7% of all patients received GCC (stage 1: 20%; stage 2: 40%; stage 3: 69%; stage 4: 50%). Only 31% of stage 1 patients underwent surgery. Factors inversely associated with receiving GCC were Hispanic ethnicity (OR 0.78;

Indexed as

guideline-concordant carepancreatectomypancreatic cancerpancreatic neoplasmsurgery

Identifiers

PMID39857951
PMCPMC11763659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.